APOA4 and fatty liver disease: The expression of APOA4-AS and Apoa4 in the liver of human fatty liver patients and ob/ob mice showed a tendency to increase, and inhibiting APOA4-AS could significantly reduce the content of TG and TC in the blood of ob/ob mice [27].